|
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
|
5R03CA220219-02
|
$88,500
|
$88,500
|
WOOLF, CLIFFORD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
5R01CA111754-13
|
$316,635
|
$158,318
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-03
|
$235,046
|
$235,046
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-04
|
$2,102,055
|
$1,765,726
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cloud quantitative imaging for whole-body tumor burden in neurofibromatoses
|
2R42CA192600-02
|
$184,073
|
$184,073
|
WU, YIN
|
IQ MEDICAL IMAGING, LLC
|
|
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
|
5R01CA201130-03
|
$401,040
|
$401,040
|
RAMESH, VIJAYA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Phospholipid and Sphingolipid Signaling in Drosophila
|
ZIA BC 010331
|
$169,912
|
$169,912
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Single-cell DNA methylation analysis of human cancer
|
ZIA BC 011846
|
$218,409
|
$174,727
|
Aldape, Kenneth
|
CCR (NCI)
|
|
Development and validation of a predictor of meningioma recurrence
|
ZIA BC 011847
|
$72,803
|
$72,803
|
Aldape, Kenneth
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Natural History and Specimen Banking for Patients with CNS Tumors
|
ZIA BC 011768
|
$416,202
|
$416,202
|
Armstrong, Terri
|
CCR (NCI)
|
|
Outcomes and Risk of Rare Tumors
|
ZIA BC 011837
|
$138,734
|
$138,734
|
Armstrong, Terri
|
CCR (NCI)
|
|
NOB-018 Mouse Model of CNS Radiation-Induced Hypersomnia
|
ZIG BC 011836
|
$138,734
|
$138,734
|
Armstrong, Terri
|
CCR (NCI)
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$358,849
|
$35,885
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$230,689
|
Barr, Frederic
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
$132,238
|
Beutler, John
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
$39,644
|
Bottaro, Donald
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$387,112
|
$116,134
|
Buck, Christopher
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$6,900
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Molecular Profiling of Patients Undergoing Radiotherapy
|
ZIA SC 010372
|
$354,054
|
$247,838
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$826,126
|
$660,901
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$856,456
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$474,287
|
$71,143
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$474,287
|
$166,001
|
Daar, Ira
|
CCR (NCI)
|
|
Rare Tumor Patient Engagement Network - Cures
|
ZID BC 011856
|
$286,416
|
$143,208
|
Dahut, William
|
CCR (NCI)
|
|
Effects of Cytosine Modifications on Transcription Factor Binding
|
ZIC BC 011724
|
$143,307
|
$143,307
|
Durell, Stewart
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$732,342
|
$36,617
|
Figg, William
|
CCR (NCI)
|
|
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
|
ZIA BC 011640
|
$217,982
|
$217,982
|
Gilbert, Mark
|
CCR (NCI)
|
|
Rare Central Nervous System Cancers Initiative
|
ZIA BC 011643
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Identifying New Glioma-Associated Tumor Suppressors & Oncogenes
|
ZIA BC 011647
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Immunotherapy
|
ZIA BC 011714
|
$305,175
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
Bioinformatics: Characterizing Brain Tumor Data
|
ZIA BC 011784
|
$87,193
|
$87,193
|
Gilbert, Mark
|
CCR (NCI)
|
|
CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures
|
ZIA BC 011853
|
$381,941
|
$381,941
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pre-clinical Translational Research Facility
|
ZIC BC 011641
|
$1,395,088
|
$1,395,088
|
Gilbert, Mark
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011642
|
$1,743,859
|
$1,743,859
|
Gilbert, Mark
|
CCR (NCI)
|
|
Pediatric Oncology Branch Behavioral Science Core
|
ZID BC 011517
|
$865,625
|
$865,625
|
Glod, John
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
$1,385,000
|
Glod, John
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$105,265
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$815,028
|
$163,006
|
Gu, Shuo
|
CCR (NCI)
|
|
Development of new antibody-based cancer therapies
|
ZIA BC 010891
|
$1,311,617
|
$1,311,617
|
Ho, Mitchell
|
CCR (NCI)
|
|
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson
|
ZIA BC 011685
|
$36,657
|
$36,656
|
Jackson, Sadhana
|
CCR (NCI)
|
|
Modulating BBB Permeability in Malignant Glioma
|
ZIA BC 011686
|
$329,909
|
$329,908
|
Jackson, Sadhana
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$344,939
|
$17,247
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$75,857
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$379,286
|
$75,857
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
|
ZIA BC 010795
|
$582,504
|
$291,252
|
Kashlev, Mikhail
|
CCR (NCI)
|
|
Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma
|
ZIA BC 010806
|
$175,604
|
$87,802
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,810
|
$237,065
|
Khan, Javed
|
CCR (NCI)
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$351,207
|
$351,207
|
Khan, Javed
|
CCR (NCI)
|
Total relevant funding to Nervous System for this search: $35,178,270
|